These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19698122)

  • 1. Expression and prognostic significance of THBS1, Cyr61 and CTGF in esophageal squamous cell carcinoma.
    Zhou ZQ; Cao WH; Xie JJ; Lin J; Shen ZY; Zhang QY; Shen JH; Xu LY; Li EM
    BMC Cancer; 2009 Aug; 9():291. PubMed ID: 19698122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of CYR61 and CTGF in the fascin-mediated proliferation and invasiveness of esophageal squamous cell carcinomas cells.
    Xie JJ; Xu LY; Wu JY; Shen ZY; Zhao Q; Du ZP; Lv Z; Gu W; Pan F; Xu XE; Xie D; Li EM
    Am J Pathol; 2010 Feb; 176(2):939-51. PubMed ID: 20056838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Connective tissue growth factor expression in precancerous lesions of human esophageal epithelium and prognostic significance in esophageal squamous cell carcinoma.
    Li LY; Li EM; Wu ZY; Huang X; Shen JH; Xu XE; Wu JY; Huang Q; Xu LY
    Dis Esophagus; 2011 Jul; 24(5):337-45. PubMed ID: 21143696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of altered expression of SDC2 and CYR61 in esophageal squamous cell carcinoma.
    Huang X; Xiao DW; Xu LY; Zhong HJ; Liao LD; Xie ZF; Li EM
    Oncol Rep; 2009 Apr; 21(4):1123-9. PubMed ID: 19288017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyr61 promotes CD204 expression and the migration of macrophages via MEK/ERK pathway in esophageal squamous cell carcinoma.
    Shigeoka M; Urakawa N; Nishio M; Takase N; Utsunomiya S; Akiyama H; Kakeji Y; Komori T; Koma Y; Yokozaki H
    Cancer Med; 2015 Mar; 4(3):437-46. PubMed ID: 25620088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma.
    Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H
    Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Cyr61, CTGF, and WISP-1 correlates with clinical features of lung cancer.
    Chen PP; Li WJ; Wang Y; Zhao S; Li DY; Feng LY; Shi XL; Koeffler HP; Tong XJ; Xie D
    PLoS One; 2007 Jun; 2(6):e534. PubMed ID: 17579708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive correlation of cysteine-rich 61 and target genes of Wnt/β-catenin pathway in esophageal squamous cell carcinoma.
    Wang P; Li L; Li T
    J Cancer Res Ther; 2016 Oct; 12(Supplement):19-22. PubMed ID: 27721245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma.
    Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I
    J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vav1 expression is increased in esophageal squamous cell carcinoma and indicates poor prognosis.
    Zhu X; Jin H; Xia Z; Wu X; Yang M; Zhang H; Shang X; Cheng R; Zhan Z; Yu Z
    Biochem Biophys Res Commun; 2017 Apr; 486(2):571-576. PubMed ID: 28336434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of Sirtuin-1 is associated with poor clinical outcome in esophageal squamous cell carcinoma.
    He Z; Yi J; Jin L; Pan B; Chen L; Song H
    Tumour Biol; 2016 Jun; 37(6):7139-48. PubMed ID: 26662958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased Tumor Suppressor Candidate 3 Predicts Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma.
    Yu X; Zhang J; Zhong H; Liu F; Liang N; Wang Y; Meng X; Du J
    Int J Med Sci; 2016; 13(12):963-969. PubMed ID: 27994502
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced stratifin expression can serve as an independent prognostic factor for poor survival in patients with esophageal squamous cell carcinoma.
    Ren HZ; Pan GQ; Wang JS; Wen JF; Wang KS; Luo GQ; Shan XZ
    Dig Dis Sci; 2010 Sep; 55(9):2552-60. PubMed ID: 20108042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cysteine-rich 61 is correlated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Xie JJ; Xu LY; Wu ZY; Li LY; Xu XE; Wu JY; Huang Q; Li EM
    Eur J Surg Oncol; 2011 Aug; 37(8):669-74. PubMed ID: 21664098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CTGF and Cyr61 in colorectal cancer.
    Ladwa R; Pringle H; Kumar R; West K
    J Clin Pathol; 2011 Jan; 64(1):58-64. PubMed ID: 21081514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of TACC3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Huang ZL; Lin ZR; Xiao YR; Cao X; Zhu LC; Zeng MS; Zhong Q; Wen ZS
    Oncotarget; 2015 Mar; 6(9):6850-61. PubMed ID: 25760075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel staging model to classify oesophageal squamous cell carcinoma patients in China.
    Tan H; Zhang H; Xie J; Chen B; Wen C; Guo X; Zhao Q; Wu Z; Shen J; Wu J; Xu X; Li E; Xu L; Wang X
    Br J Cancer; 2014 Apr; 110(8):2109-15. PubMed ID: 24569468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High expression of GOLPH3 in esophageal squamous cell carcinoma correlates with poor prognosis.
    Wang JH; Chen XT; Wen ZS; Zheng M; Deng JM; Wang MZ; Lin HX; Chen K; Li J; Yun JP; Luo RZ; Song LB
    PLoS One; 2012; 7(10):e45622. PubMed ID: 23056210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumor-suppressive role of BATF2 in esophageal squamous cell carcinoma.
    Han T; Wang Z; Yang Y; Shu T; Li W; Liu D; Li P; Qi R; Ren Y; Li L; Liu H; Zhang S; Zhang L
    Oncol Rep; 2015 Sep; 34(3):1353-60. PubMed ID: 26135942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Roles of ezrin in the growth and invasiveness of esophageal squamous carcinoma cells.
    Xie JJ; Xu LY; Xie YM; Zhang HH; Cai WJ; Zhou F; Shen ZY; Li EM
    Int J Cancer; 2009 Jun; 124(11):2549-58. PubMed ID: 19165868
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.